In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
<p>Abstract</p> <p>Background</p> <p>Traditionally, drugs were discovered by testing compounds synthesized in time consuming multi-step processes against a battery of in vivo biological screens. Promising compounds were then further studied in development, where their p...
Main Authors: | Roy Paushali, Basu Protip, Mazumder Manjita, Ganguli Sayak, Mitra Sayani, Datta Abhijit |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-01-01
|
Series: | BMC Bioinformatics |
Similar Items
-
Retraction: In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
by: Roy Paushali, et al.
Published: (2010-05-01) -
In silico analysis of compounds from Stemona tuberosa as an inhibitor for N1 neuraminidase of H5N1 avian virus
by: Abhilash Manohar
Published: (2013-02-01) -
<it>In-Silico </it>screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain
by: Hussain Basha Syed, et al.
Published: (2012-02-01) -
In silico Investigation of Drug-Target Interactions for N1 Neuraminidase
by: I-Ching Wu, et al.
Published: (2008) -
Neuraminidase-inhibiting antibodies and protective immunity elicited by recombinant neuraminidase proteins of H5N1 and pH1N1 Influenza A Viruses
by: Tsou, Yung-Ta, et al.
Published: (2013)